Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 29.60
-0.05 (-0.17%)
Sep 8, 2026, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 16 billion as of September 4, 2026. Its market cap has decreased by -8.44% in one year.
Market Cap
16.00B
Enterprise Value
17.77B
Revenue
6.68B
Ranking
n/a
PE Ratio
19.40
Stock Price
29.60
ChartMarket Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 16.00B, an increase of 2,642.45%. That is a compound annual growth rate of 17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 16.00B | -1.51% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 23.85B |
| TTY Biopharm Company | 19.15B |
| Handa Pharmaceuticals | 17.47B |
| ScinoPharm Taiwan | 15.10B |
| YungShin Global Holding | 14.94B |
| Grape King Bio | 13.41B |
| Foresee Pharmaceuticals | 12.60B |
| Standard Chemical & Pharmaceutical | 10.01B |